|
Cholesterol, LDL
|
D04.210.500.247.808.197.244 |
|
|
Glucagon-Secreting Cells
|
A06.390.087 |
|
|
Cholesterol, VLDL
|
D04.210.500.247.808.197.247 |
|
|
Complement C4b
|
D12.776.124.486.274.350.260 |
|
|
Colistin
|
D12.644.050.600.110 |
|
|
Diverticulum, Colon
|
C23.300.415.500 |
|
|
Opioid-Related Disorders
|
C25.775.643.500 |
|
|
Narcotic-Related Disorders
|
C25.775.643 |
|
|
Teicoplanin
|
D12.644.233.352.500 |
|
|
Lipoglycopeptides
|
D12.644.233.352 |
|
|
Eye Burns
|
C10.900.300.284.250.250 |
|
|
CD40 Antigens
|
D23.050.301.264.051.140 |
|
|
Arrestins
|
D12.776.476.024.104 |
|
|
Matched-Pair Analysis
|
N06.850.520.830.475 |
|
|
Epidermolysis Bullosa Simplex
|
C16.320.850.275.180 |
|
|
Monoclonal Gammopathy of Undetermined Significance
|
C20.683.460.640 |
|
|
Tooth Germ
|
A14.549.167.900.720 |
|
|
Chemokine CXCL2
|
D23.469.200.600.940 |
|
|
Epilepsy, Tonic-Clonic
|
C10.228.140.490.375.290 |
|
|
Azlocillin
|
D02.886.108.750.750.050.075 |
|
